The AcelRx banner promotions submitted to the FDA (above) for approval got the opioid drug maker a warning letter for being misleading. (FDA).
FDA rebukes AcelRx's flippant 'tongue and done' promo for potent opioid drug Dsuvia
- Written by: Drug News Feed
- Category: Drug News
- Hits: 377